T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients
Published inAnnals of oncology, vol. 33, no. 12, p. 1333-1335
Publication date2022-12
First online date2022-09-16
Keywords
- Humans
- SARS-CoV-2
- T-Lymphocytes
- COVID-19 / prevention & control
- Receptors, Antigen, T-Cell
- Transplant Recipients
- Vaccination
- Hematopoietic Stem Cell Transplantation / adverse effects
Citation (ISO format)
PRADIER, Amandine et al. T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients. In: Annals of oncology, 2022, vol. 33, n° 12, p. 1333–1335. doi: 10.1016/j.annonc.2022.09.153
Main files (1)
Article (Published version)
![accessLevelPublic](assets/images/access-level-free.png)
Secondary files (3)
Identifiers
- PID : unige:169315
- DOI : 10.1016/j.annonc.2022.09.153
- PMID : 36116692
- PMCID : PMC9477612
ISSN of the journal1569-8041